Skip to main content

Table 2 Classification of variants in study cohort according to the VEP

From: Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma

Type of variants Number of mutations
Missense 346
Benign mutations 127
Modifying 0
Nonsense 6
Frameshift 13
Splicing site 1
Inframe insertion and deletion 37
Nonstop mutation 0
Total 530
\